Whalegun
Home

Adrian Rawcliffe, CEO: Adaptimmune Therapeutics ADAPY Sell · Filed 25/01/17

Trade details

Type
Insider sale
Amount
$17,748.58
Shares · price
30,601 sh · $0.58 a share
Held after
44,327 sh
Stock
Adaptimmune Therapeutics ADAPY
Person
Adrian RawcliffeCEO
Trade date
25/01/17
Filed
25/01/17
Days to filing
0 days

Sold 40.8% of holdings

Share of holding sold
40.8%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/18~25/02/16

Adrian Rawcliffe's recent trades

  • Adrian Rawcliffe

    Planned sale10b5-1 planWave Life Sciences

    $64.1K

    Filed 08/12

  • Adrian Rawcliffe

    Sell10b5-1 planWave Life Sciences

    $630K

    Filed 25/12/10

  • Adrian Rawcliffe

    Planned sale10b5-1 planWave Life Sciences

    $314.6K

    Filed 25/12/08

  • Adrian Rawcliffe

    Sell10b5-1 planWave Life Sciences

    $109.4K

    Filed 25/11/14

  • Adrian Rawcliffe

    Planned sale10b5-1 planWave Life Sciences

    $112.1K

    Filed 25/11/13